Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:36:33.712Z.
Calculation as of: 2026-10-06T19:36:33.712Z.
Quote observation: 2026-10-06T19:35:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f97479f440d7a03605f533a56e26179237db48e588053495707f458dff3bcd44
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$5.03B
EV/EBIT Ratio
23.57x
TTM Avg
25.06x
3Y Avg
41.40x
5Y Avg
41.40x
Market Cap
$5.03B
EV/EBIT Ratio
26.84x
TTM Avg
27.45x
3Y Avg
34.84x
5Y Avg
44.16x
Market Cap
$5.08B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
EV/EBIT Ratio
59.39x
TTM Avg
192.46x
3Y Avg
192.46x
5Y Avg
192.46x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $4.94B | N/A | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.03B | 23.57x | 25.06x | 41.40x | 41.40x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.03B | 26.84x | 27.45x | 34.84x | 44.16x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.08B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.78B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.77B | N/A | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.13B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 59.39x | 192.46x | 192.46x | 192.46x |
| Sotera Health Company (SHC)vs › | $5.20B | 16.13x | 17.80x | 19.80x | 22.70x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
